Company Profile

Globus Medical Stock Price, News & Catalysts

Ticker:
GMED
Exchange:
NYSE
Sector:
Biopharma
Location:
United States

Stock performance

85.12 USD (-0.91%)

Close

Last updated: August 17, 2026

10.6B USD

Market cap

Why the stock is moving

As of Aug 17, 2026, GMED closed down 0.91% at $85.12. No new same-company headline was identified in the current news window.

Company overview

Musculoskeletal Technology

Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation.

Implants and Enabling Technologies

The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction procedures.

Enabling Technologies

Globus provides navigation, imaging and robotic systems that support surgical planning and execution. These technologies create a broader procedural ecosystem around its implant portfolio.

Expanded Pain-Management Platform

Through Nevro, Globus also participates in spinal-cord stimulation and other neuromodulation therapies for chronic pain, broadening the company beyond its traditional spine and orthopedic markets.

Future catalysts

    Recent news

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Globus Medical (GMED)?

    Globus Medical (GMED) most recently closed at 85.12 USD, a -0.91% move versus the previous session.

    What is the market cap of Globus Medical (GMED)?

    Globus Medical currently has a market capitalization of 10.6B USD on BioPharmSignal.

    What does Globus Medical do?

    Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation. Implants and Enabling Technologies The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction...

    On which exchange is GMED stock listed?

    Globus Medical (GMED) is associated with NYSE, United States, Biopharma.

    What is Musculoskeletal?

    Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care.

    Which conditions is Globus Medical targeting with Musculoskeletal?

    Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation. Implants and Enabling Technologies The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction...

    What is Technology?

    Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care.

    What is Globus?

    Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care.